New York, New York–(Newsfile Corp. – December 29, 2024) – FOR WHAT: Rosen Law Firm, an international investor rights law firm, reminds purchasers of Dentsply Sirona Inc. (NASDAQ: XRAY) common stock between February 28, 2022 and November 6, 2024, both dates inclusive ( the “Class Period”), important Deadline of January 27, 2025 for principal applicant.
AND THEN: If you purchased Dentsply Sirona common stock during the Class Period, you may be entitled to compensation without payment of any fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Dentsply Sirona class action, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. at 866-767-3653 or email case@rosenlegal.com for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the court no later than January 27, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY THE ROSEN LAW: We encourage investors to select qualified advisors with a proven track record in leadership roles. Often, companies issuing reviews do not have significant experience, resources, or peer recognition. Many of these firms do not actually defend securities class actions, but are simply intermediaries that refer clients or partner with law firms that actually litigate cases. Be careful when choosing a lawyer. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. The Rosen Law Firm obtained the largest securities class action settlement against a Chinese company at the time. Rosen Law Firm Ranked #1 by ISS Securities Class Action (WA:) Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of the Plaintiffs Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
CASE DETAILS: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Dentsply Sirona targeted low-income individuals who did not have access to a good oral hygiene education, a dentist, or dental insurance, which often meant that patients signing up for Byte, a direct-to-consumer (“DTC”) aligner solution, had problems dental underlying conditions which would have made them ineligible for treatment; (2) pressure for byte growth and sales commissions caused salespeople to sell to contraindicated patients; (3) as a result of the foregoing, Byte’s patient onboarding workflow did not provide adequate assurance that contraindicated patients were not initiated on treatment; (4) before and during the Class Period, reports of Byte patient injuries were rife; (5) Dentsply Sirona knew for years that its Byte aligners were causing serious patient injuries, but did little to investigate these injuries or notify the U.S. Food and Drug Administration (“FDA”). United; (6) Dentsply Sirona did not have a system in place to notify the FDA of these injuries, which Dentsply Sirona is required to do within 30 days of becoming aware of a problem; (7) the FDA has received a sharp increase in reports of serious injuries to Byte patients; (8) as a result of the foregoing, Dentsply Sirona significantly overestimated the value of Byte’s goodwill; and (9) as a result of the foregoing, Defendants’ positive statements regarding Dentsply Sirona’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details were leaked to the market, the lawsuit claims, investors suffered damages.
To join the Dentsply Sirona class action, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.
No classes have been certified. Until a class is certified, you are not represented by an attorney unless you retain one. You can choose the lawyer of your choice. You can also remain an absent member of the group and do nothing at this point. An investor’s ability to participate in any potential future recovery is not dependent on its status as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:) : https://www.facebook.com/rosenlawfirm/.
Lawyer advertising. Previous results do not guarantee a similar result.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235173
